Overview
Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with.
Dr. Naik is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.
Her clinical research consists of co-authoring 83 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles in the study of Thrombocytopenia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
600 North Wolfe Street, Park BLDG, STE 110, Park BLDG, STE 110, Baltimore, MD 21287
300 Mason Lord Drive, Kimmel Cancer Center, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.
Johns Hopkins University
Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.
American Oncology Partners PA
David Smith is a Hematologist and an Oncologist in Easton, Maryland. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Myelodysplastic Syndrome (MDS).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Sickle Cell DiseaseDr. Naik isElite. Learn about Sickle Cell Disease.
- Distinguished
- AnemiaDr. Naik isDistinguished. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Naik isDistinguished. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Naik isDistinguished. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Naik isDistinguished. Learn about Hemolytic Anemia.
- Advanced
- Adult Immune ThrombocytopeniaDr. Naik isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Ataxia-Pancytopenia SyndromeDr. Naik isAdvanced. Learn about Ataxia-Pancytopenia Syndrome.
- Autoimmune Hemolytic AnemiaDr. Naik isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Deep Vein ThrombosisDr. Naik isAdvanced. Learn about Deep Vein Thrombosis.
- Essential ThrombocythemiaDr. Naik isAdvanced. Learn about Essential Thrombocythemia.
- Fanconi AnemiaDr. Naik isAdvanced. Learn about Fanconi Anemia.
- Experienced
- Acquired AgranulocytosisDr. Naik isExperienced. Learn about Acquired Agranulocytosis.
- Acquired HemophiliaDr. Naik isExperienced. Learn about Acquired Hemophilia.
- Acute Eosinophilic PneumoniaDr. Naik isExperienced. Learn about Acute Eosinophilic Pneumonia.
- AgranulocytosisDr. Naik isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Naik isExperienced. Learn about Alpha Thalassemia.
- Antiphospholipid SyndromeDr. Naik isExperienced. Learn about Antiphospholipid Syndrome.